Targeting glucose production in liver may lead to new diabetes therapies

A biological checkpoint known as the Mitochondrial Pyruvate Carrier is critical for controlling glucose production in the liver and could potentially be a new target for drugs to treat diabetes, new research shows.http://dlvr.it/C3lYjz